Blade Therapeutics Funding & Investors
South San Francisco, CA
Blade Therapeutics, Inc. operates as a biopharmaceutical company for treating fibrosis. The Company offers screening, drug discovery and development, tissue replacement, and fibrotic disease management. Blade Therapeutics conducts its business in the United States.
blademed.comTotal Amount Raised: $51,500,000
Blade Therapeutics Funding Rounds
Series B
$45,000,000
Series B Investors
Deerfield ManagementPfizer Venture InvestmentsBristol-Myers Squibb CompanyMPM CapitalOsage University Partners IINovartis InstitutesSeries A
$6,500,000
Series A Investors
MPM CapitalOsage University Partners II
Funding info provided by Diffbot.